er the name, it’s fueling a shadow economy most  people don’t even know exists. It’s massive. It’s underground.  And it’s just getting started. I’m Josh, and on today’s episode  of The Infographics Show, we’re revealing why everyone  is injecting ‘Magic Juice.’ Chapter One: The Cold War Blueprints This all traces back to 1973, when  the Soviet Union ran into a serious problem… their soldiers were aging too fast. The condition was amplified in critical roles. Submariners. Missile operators. Fighter  pilots. The stress, the isolation, and a… not insignificant amount of radiation all  played a role. The men were breaking down and at the height of the Cold War, worn-out  soldiers were a strategic liability. The USSR Ministry of Defence  did what it always did. They brought in a military physician,  Vladimir Khavinson. Years later, he’d become Putin’s personal anti-aging  doctor. They gave him access to a secret lab in Leningrad… and told him to fix it. Khavinson didn’t find what they were looking for. He found something stranger. Your body is essentially a massive  construction site operating in total darkness. No one can see the blueprints.  No one knows what to build or when to stop. So your cells send tiny molecular text  messages instead. Connect the amino acids, and you get a peptide: a message delivered  straight to the cellular workers, telling them exactly what to build,  when to build it, and when to stop. Some of those messages can even tell an  aging cell to behave like a young one. That’s what Khavinson found. And he spent the next four decades  figuring out what to do with it. He published 775 scientific papers, filed 196  patents, treated cosmonauts, Chernobyl survivors, and submariners. He died in 2024 at 77, largely  unknown in the West. The Cold War had kept an iron curtain between his research and the  scientists who might have replicated it. At the same time, the West was developing  its own relationship with peptides. Although it was much sweatier. In the 1990s, the bodybuilding community  had figured out they could manipulate growth hormone by using peptides to  trigger the pituitary gland. Hulking athletes in gyms from Venice Beach  to Eastern Europe realized they could message their own endocrine systems  into producing more of everything. We call it biohacking. They called it getting jacked. The peer review process consisted of  one guy in the gym telling another guy it worked. Honestly, for  their purposes, that was enough. Then, in the early 1990s, a Croatian researcher at  the University of Zagreb - Predrag Sikiric - did something that would shake the biohacking  world. He isolated a 15-amino-acid chain from a protein in human gastric juice and  discovered it did something no one expected. He called it Body Protection Compound  157, or BPC-157. When he tested it on rats, it healed things. Tendons,  ligaments, gut tissue, muscle fiber. Not slowly. Not partially. Completely. BPC-157 seemed to work by turbocharging  something called angiogenesis, or the growth of new blood vessels. This  essentially rebuilt the entire blood supply to damaged tissue at a speed that had no  clinical parallel or framework to explain. The biohacking world named it after the  only cultural reference that came close. Wolverine. The Marvel superhero  who regenerates tissue, organs, and limbs in real time. And that name is what  launched a billion-dollar underground industry. Chapter 2: The Trillion-Dollar Demographics On an online forum called looksmaxxing.com, there is a thread titled, “Would you  guys recommend peptides for someone 17?” One of the first replies is from a  user with over 2,000 posts and 4,000 reputation points. His answer is telling:  “I’m 16 on peptides, and yes I would.” That’s just the tip of the looksmaxxing iceberg. It’s a corner of the internet -  mostly teenage boys - obsessed with optimizing their appearance through  every possible lever: jawline exercises, posture correction, skin routines,  and increasingly, peptide injections. And before you assume this is just  a fringe activity in a few bedrooms, New York and New Jersey have passed  laws banning the sale of peptides and performance enhancing compounds to  minors. They did it because teens were already buying them freely - at scale  - from vendors who asked zero questions But it isn’t just teenagers. Recently, a patient walked into  a Washington D.C. doctor’s office carrying a Trader Joe’s fridge bag. When  she pulled out a handful of syringes, her doctor assumed they were  GLP-1s. Ozempic. Zepbound. They weren’t. Her bag was full of something she called a  Wolverine Stack, a combination of peptides ordered online. They promised to heal her torn rotator  cuff faster than physical therapy ever could. She'd spent, in her doctor's words, "oodles of money" on a 3 month supply  and was injecting herself daily. “My trainer swears by it,” she  said. “Everyone is using them.” A stack, by the way, is exactly what it sounds  like. Layering multiple peptides on top of each other, each one theoretically targeting a  different biological system simultaneously. Think of it like a custom medicinal playlist, except every ‘song’ is an unregulated injectable…  and hitting shuffle could give you sepsis. The patient with the Trader  Joe’s bag is not an outlier. She is the demographic portrait  of where this market has arrived. On July 4th, 2025, podcast host  Jayden Clark was at a party in the backyard of a San Francisco  Victorian. Soon an AI founder casually mentioned his Chinese peptide  supplier. A crowd formed immediately. Everyone, it turned out, had a source. Clark posted about it on X: "Something I have learned… is that the elites all  have a Chinese peptide dealer." The post went viral. The term became a meme. And the meme was accurate. Gray-market peptides have  since flooded hacker houses, startup offices, and - this is real -  peptide raves sponsored by suppliers. One recent event at Frontier Tower in  San Francisco featured a mix-your-own peptides workshop. A DJ played techno  while chemistry structures projected in the background. The dress code called  for "crazy futuristic cyberpunk attire." Attendees were shown how to draw their own blood. The FDA was not on the guestlist. At a Manhattan biohacker meetup, one tech investor  described the weekly scene with the kind of casual horror only someone who's been doing it for seven  years could muster: "Each week someone will bring something new, and everyone will inject it…  it looks like a bunch of heroin addicts." He said it as a joke. He has been microdosing peptides since 2018. The substances being injected at these gatherings  read like a speculative biology syllabus. There’s a copper-based peptide for skin-regeneration,  recently profiled in Vogue. BPC-157 for injury healing. Ipamorelin and CJC-1295 for growth  hormone release, being used by teenagers whose brains aren't finished developing yet.  Epitalon for sleep. Retatrutide, still in Phase 3 clinical trials, for appetite, focus, and  apparently everything else. And oxytocin, which an OpenAI researcher publicly called "Ozempic for  autism," being microdosed for social optimization. Silicon Valley engineers are injecting a  compound just to make more eye contact. None of this is happening under medical  supervision. It's happening on Reddit threads and Discord servers. YouTube influencers  are holding up vials of clear liquid and saying "I had tendonitis in my elbow, I started  using BPC-157, and it was gone in two weeks." That last quote, by the way,  is from Joe Rogan. Verbatim. One San Francisco peptide supplier broke down  the diffusion pattern with accidental poetry: "It always starts with the CEOs, then  CTOs, then COOs. Biopharma people are shockingly the most reserved–they're  a little too deferential to the FDA." His average customer, he noted, is closer  to a Starbucks barista. "But the techies were first," he said, "because of the  willingness to take ridiculous risks." The anti-aging clinic industry commands  an economy unto itself. Businesses charge $350 to $600 per peptide  protocol per session. Gary Brecka, who calls himself the "Ultimate Human," sells  peptide injectables through his website and appeared on a podcast to evangelize  the category to millions of listeners. Brecka’s marketing is a masterclass in  sounding scientific while saying nothing. Browse his site's "approved and recommended"  $350 CJC-1295 and Ipamorelin stack and click the "Who It's For" tab. You get:  "Individuals incorporating peptide support into structured recovery, training,  or wellness protocols who want a synergistic dual-peptide option that supports hormone  signaling pathways and tissue maintenance." It’s as clear as mud. Priced like crystal. If you want to watch people ignore  common sense in the most creative ways, make sure to like, share, and  subscribe. We’ve got plenty more videos where we explain stuff  people probably shouldn’t be doing. According to U.S. Customs data, imports of hormone  and peptide compounds from China roughly doubled to $328 million in the first three quarters of  2025. That’s up from $164 million the year before. But it’s probably more. Nobody has a clean estimate of  how much more is moving through misdeclared packages and domestic  reshipping operations. The legal global peptide therapeutics market alone  is projected to hit $294.6 billion by 2033. The gray market isn't a rounding  error. It is its own industry. And it all runs through one country. Chapter 3: The Federal Paradox This entire situation feels almost designed  to produce the exact disaster it created. The FDA didn’t ban peptides because people were  dying. In late 2023, they quietly moved 19 popular peptides onto something called the Category  2 bulk drug substances list. That effectively prohibited compounding pharmacies from preparing  them. The stated rationale was that there was insufficient safety data, immunogenicity  concerns, manufacturing quality issues. All of which is true. And none of this explains why these  specific peptides were singled out, especially when thousands of other  compounds have equal or weaker evidence. For that explanation, you  have to follow the money. Getting a drug approved can range anywhere  from tens of millions to several billion dollars in clinical trials. The only way  to make that back is a patent. You get 20 years of exclusive sales while every  competitor watches from the sidelines. That's the deal. That's always the deal. Here's the problem, though. These peptides  weren't invented in a lab. They already exist inside you. BPC-157 is a direct fragment of  a healing protein that lives in your stomach right now. TB-500 mimics something your immune  system produces every time you get hurt. You cannot patent something your own body makes. So nobody funds the trials. The FDA never gets the evidence it needs to approve them.  And these compounds get stuck in a kind of permanent legal purgatory. They’re available  to anyone with a credit card and a browser, but impossible for any licensed doctor to  prescribe or any licensed pharmacy to fill. A law-abiding citizen actually has  fewer legitimate options here than someone willing to buy from a stranger online. In 2023, the FDA took this already broken  situation and made it worse. They banned compounding pharmacies, the one legitimate  middle ground that actually functioned. These were the licensed facilities  where physicians could order peptides for specific patients, with quality controls,  sterility testing, and real medical oversight. The kind of infrastructure you'd want between a  patient and an experimental injectable compound. Gone. Banned overnight. Did people stop using peptides? No. Demand just picked up and relocated straight to WhatsApp, factories in Guangdong Province, and  the veins of people who now had no other option. Chapter 4: The Chinese Shadow Market Dr. Paul Abramson, a concierge  physician in San Francisco, has watched peptide use explode among  his young tech patients. He described the procurement process this way: "It's not  like funding a scrappy startup. It's wiring money to an unregistered offshore  entity based on a pitch deck." Here’s the pitch deck. A vial of BPC-157 begins its journey on  the Chinese social media platform known as RedNote. The sellers operate with  a confidence that makes it seem like they’ve never once worried about the consequences One undercover journalist found a seller  whose account showed refrigerators full of color-coded peptide vials. The moment contact  was made, the conversation moved straight to WhatsApp. Ten vials minimum order; $60 shipping.  About $48 total for ten vials of tirzepatide, the active ingredient in Zepbound, which Eli  Lilly sells to American patients for $399 a month. The markup between Chinese factories and U.S.  pharmacies is roughly 800%. Someone is making an extraordinary amount of money on that gap.  It is not the person doing the injecting. The legal fiction holding the whole operation  together is three words: "Research Use Only." Under U.S. federal law, selling BPC-157 is  technically legal as long as it's marketed for laboratory research. So every vendor website is  wallpapered in disclaimers. "Not for human use." "For research purposes only." "Not intended to  diagnose, treat, cure, or prevent any disease." It is a legal pinky-swear. A liability shield that transfers 100% of the risk to the buyer. Both  parties understand exactly what's happening. When a journalist asked a Chinese factory  operator directly whether they knew their Western customers were injecting these  products, the operator didn't hesitate. "Yes." That's it. That was the whole answer. Customs is where things get creative.  Shipments arrive hidden in cosmetics packaging, labeled vaguely enough to pass inspection.  Or, they’re bulk-shipped to U.S. addresses, where individual USPS labels are added before  delivery. It’s a domestic reshipping operation that keeps the international leg of the  journey invisible to inspectors. Customs and Border Protection has been  aware of this system for years. Their enforcement record on personal-quantity  peptide imports is essentially nonexistent. So no, the risk here is not arrest. The risk is considerably more personal than that. The risk is opening a package from Guangdong  and discovering the hard way that what’s inside isn’t what you ordered. Chapter 5: The Vigilante Testers The gray market quality problem is  far worse than most users realize… and most users already know it’s bad. Multiple studies have found that between 20 and 60% of gray-market peptides  contained incorrect amino acid sequences. That means nearly half of what  people inject isn’t even the intended compound. It’s just something  else in a vial with a convincing label. On top of that, a significant portion of  tested samples exceeded safety thresholds for endotoxin contamination. Meaning  bacterial byproducts that, when injected, trigger systemic inflammation or,  in serious cases, septic shock. Traces of heavy metals - lead, arsenic, mercury - are showing up as leftover  byproducts in compounds people are injecting directly into their bloodstream. Technically, two things can be true. Your vial might test as chemically 99% pure  with a correct molecule and concentration. But it can still be a tiny biological soup  kitchen for things that want to kill you. So the biohacking community did what any  reasonable group would do when faced with a completely unregulated injectable market. They formed a committee. They crowdfund money to send batches  to independent labs - Janoshik in the Czech Republic and Finnrick in Texas - which  specialize in testing gray-market compounds. Results get posted publicly in forums  and Discord servers. Vendors who pass get recommended. Vendors who fail get dragged. It is a fully functioning consumer protection apparatus for an entirely illegal market, built  by amateurs on the internet in their spare time. The problem is that Certificates of Analysis  are trivially easy to photoshop. Vendors can pass legitimate tests on one batch and quietly  ship a completely different one. Even a genuine, freshly issued certificate tells you  nothing about sterility. Nothing about endotoxin levels. And nothing about whether  the compound was stored correctly. That’s critical for peptides, which degrade  quickly when exposed to heat or light. Especially during a two-week journey from  China in the back of a cargo container. Which brings us to Brooke Bowman. Brooke is 38. She’s the CEO of Vibecamp, an  annual gathering of the rationalist community, and she did everything right. Everything  the community considers responsible, anyway. She logged every injection in the Peptide  Tracker app. She monitored her sleep and heart rate obsessively. She got regular bloodwork.  She started on BPC-157 and TB-500 for chronic fatigue, then added retatrutide for theoretical  cognitive benefits and to help her quit vaping. She was, by the standards of this  particular subculture, a model citizen. One day, she accidentally doubled her dose. Her hair started falling out  within a month. Her resting heart rate jumped 10 beats per minute. She says she plans to keep going. She also mentioned that she got clean  from heroin in 2020. Peptides scratch a similar itch. "I'm not getting  that from heroin anymore," she said. "So it's fun to have a new thing I'm  experimenting with that isn't horrible." Another shipment from China  was already on its way. Chapter 6: The Cancer Paradox There’s something else the  forums don’t talk about much. The reason people use BPC-157 and TB-500 is the  exact same reason doctors lose sleep over them. Both compounds work - if they work  at all in humans - by promoting something called angiogenesis.  The growth of new blood vessels. This is the mechanism behind every headline  claim you've seen. "Healed my tendon in two weeks." "Fixed my gut." "Shoulder injury gone."  Angiogenesis works by rebuilding damaged tissue. It restores blood supply to the area, essentially  regrowing the infrastructure the body needs to repair itself. Sounds great. But angiogenesis is also how tumors grow. Cancer cells are not magic. They need oxygen. They need nutrients. They get both through  blood vessels, just like everything else in your body. And one of the first things a tumor  does when it starts to grow is send out chemical distress signals to recruit new blood vessels.  This process is called tumor angiogenesis. It’s so fundamental to how cancer spreads that  an entire generation of oncology drugs was developed for the sole purpose of blocking it. People are injecting a compound specifically designed to accelerate the growth of new blood  vessels throughout their body. If those blood vessels are feeding a healing tendon, great. If  those compounds reach a cluster of pre-cancerous cells, they might have poured gasoline on  something that was quietly going nowhere. This is not a confirmed finding. Nobody has done the study. That’s because the compounds aren't approved  and the trials simply don’t exist. But it’s a scientifically valid concern, raised  repeatedly by researchers with nothing to gain. It’s exactly the kind of warning  that gets lost in the noise of a forum full of people who feel absolutely fantastic. Dr. Eric Topol, director of the Scripps Research Translational Institute, went on record to call  the entire peptide craze "unfounded." Of 36 published studies on BPC-157 through 2024, 35 were  conducted on animals. The vast majority of all global BPC-157 research comes from a single lab. The same lab in Croatia where it was discovered. A human clinical trial began in 2015. It  was quietly canceled in 2016. The results were never published. No explanation was given.  Nobody followed up. That's the entire evidence base for something millions of people are  injecting into themselves before breakfast. So basically, magic juice users are, effectively,  gambling the house on an experiment where they are both the subject and the control group. And nobody is taking notes. Chapter 7: The RFK JR.  Disruption and the Pharma Trap On February 27th, 2026, Robert F. Kennedy  Jr. appeared on The Joe Rogan Experience and announced that 14 of the 19 peptides  the FDA banned in 2023 were about to be un-banned. Moved from Category 2 back  to Category 1. Compounding pharmacies would be able to make them again, under  physician prescription, within weeks. The biohacking community lost its mind. Every forum, every server that had spent years crowdfunding lab tests and swapping  Chinese supplier tips were taking the digital equivalent of a victory lap. RFK himself  called the original ban illegal and said it had created the gray market it  was supposedly trying to prevent. He is not wrong about that. After 2023, the gray market metastasized. The number of people injecting  unregulated, unsterile compounds from overseas went up dramatically. Rather than stopping peptide  use, the ban just pushed it underground. The FDA had essentially performed surgery to remove  a splinter and accidentally hit an artery. So yes, the reversal is a win. In one specific, narrow sense, it genuinely is. But there are still no clinical trials.  Still no safety data on what a decade of use looks like. Still no answer to the cancer  question. And while the biohacking community is celebrating the open door, the pharmaceutical  industry is quietly buying everything up. The legitimate peptide therapeutics market  is projected to double within a decade. Pharmaceutical companies are closing  deals worth hundreds of millions of dollars. These are the kinds of numbers  companies commit when they’re certain something works and racing to  own it before anyone else does. The natural molecule can't be patented. We've  established that. But tweak a few amino acids, file a new formulation claim… and  suddenly it’s $400 a month for 20 years, with a prescription your  insurance might not even cover. Suddenly the gray market loophole closes  the moment your approved version clears the FDA. Now there's a legal alternative.  The “research use only” fiction becomes a lot harder to maintain. Anyone who wants the  compound goes through the healthcare system. The same healthcare system  these companies already control. It's the oldest move in the pharmaceutical  playbook. It has worked every single time it has ever been run. Millions have been  testing these compounds on themselves. They have been generating real-world data  clinical trials are supposed to produce. The people who benefit most from RFK's  announcement are not the teenagers in Ohio, or the Silicon Valley types, or even Brooke  Bowman, waiting on her next shipment. They are the big pharma companies standing to make millions. The underground was the trials all along. And the pharmaceutical industry  got its results for free. Peptides are the part of this story where people  are at least trying to heal themselves. If you want to see what the other end of America's  unregulated drug hellscape looks like, check out The Only Drug You Can't  Survive. Or click on this video instead.